[Bone mineral loss in patients with human immunodeficiency virus infection].
Life expectancy and quality of life among patients infected with human immunodeficiency virus (HIV) has dramatically improved with the advent of highly active antiretroviral therapy. Nonetheless, with the transformation of HIV infection into a chronic disease, a series of long-term consequences have been observed, among them osteoporosis. The prevalence of this condition is increasing among individuals with HIV infection. Although an epidemic of fragility fractures has not been described in these patients, an increase in the incidence of such fractures is anticipated as the HIV population ages, and this will undoubtedly have an impact on their quality of life. The numerous factors that favor the development of osteoporosis in these patients are related to the infection, itself, and the treatment received.
Olmos
José Manuel
JM
Departamento de Medicina Interna, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, España. miromj@humv.es
González-Macías
Jesús
J
D001851:Bone Diseases, Metabolic / Q000453:epidemiology / Q000209:etiology* / Q000821:virology; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D010024:Osteoporosis / Q000453:epidemiology / Q000209:etiology* / Q000821:virology; D015995:Prevalence